MAPT and Alzheimer disease: Using a human AD and control brain lysates, researchers demonstrated that tau coimmunoprecipitates with ribosomal protein RPS6 and induced expression of Tau decreases the synthesis of ribosomal proteins (Koren et al., 2019).